跳至主要内容
临床试验/CTRI/2022/10/046928
CTRI/2022/10/046928尚未招募2 期

Clinical evaluation of effects of Hijama- Bila- Shurt (Dry Cupping) as a part of multimodal approach in the management of fibromyalgia.

Ajmal Khan Tibbiya College1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年5月11日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Improvement Criteria- it will be correlated with the subjective and objective parameters.

研究概览

简要总结

Clinical evaluation of effects of Hijama- Bila- Shurt  (Dry Cupping) as a part of multimodal approach in the management of  fibromyalgia.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •1.Clinically Diagnosed patient of FMS (Based on 2016 revision of American College of Rheumatology (ACR) Diagnostic Criteria of 2011/
  • •2.Patients who are able to give written informed consent and follow the protocol of study.
  • •3.Patients of either sex 4.Patients in age group of 20-60 years.

排除标准

  • •1.Patients below 20 years and above 60 years
  • •Primary generalized osteoarthritis, polymyalgia rheumatica, Rheumatoid arthritis, Diabetic Neuropathy,Hypothyroidism Pregnant and Lactating women
  • •Patients with uncontrolled diabetes and severe hypertension.
  • •5.Patient taking medicine for any other psycho- somatic disorders.
  • •6.History of trauma.
  • •7.Patients having anemia(Hb% less than 9gm%).
  • •8.Patients unable to give informed written consent.

结局指标

主要结局

Improvement Criteria- it will be correlated with the subjective and objective parameters.

时间窗: Every 14th day for 28 days

1.Primary Parameters

时间窗: Every 14th day for 28 days

•NRS (Numeric Rating Scale)

时间窗: Every 14th day for 28 days

0-no pain to 10-worst possible pain

时间窗: Every 14th day for 28 days

次要结局

  • 2.Secondary Parameters:(1.Revised Fibromyalgia Impact Questionaire(FIQR))

研究者

发起方
Ajmal Khan Tibbiya College
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验